Disease | pulmonary embolism |
Phenotype | C0021053|immune disease |
Sentences | 1 |
PubMedID- 24641833 | Accumulative data favored the potential use of circulating cell-free dna (cfd) in the plasma or serum for diagnosis, prognosis, and monitoring of a variety of conditions such as infection, inflammation, trauma, in critically ill patients with respiratory insufficiency or pulmonary embolism, in patients with autoimmune diseases, sepsis and cancer [13-19]. |
Page: 1